Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0004 USD
Change Today 0.00 / 0.00%
Volume 61.6M
As of 8:10 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

oncologix tech inc (OCLG) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/19/15 - $0.01
52 Week Low
10/6/15 - $0.0002
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ONCOLOGIX TECH INC (OCLG)

Related News

No related news articles were found.

oncologix tech inc (OCLG) Related Businessweek News

No Related Businessweek News Found

oncologix tech inc (OCLG) Details

Oncologix Tech, Inc., a diversified medical holding company, manufactures medical devices; and provides personal healthcare services, home medical equipment, and durable medical equipment in the United States. The company operates through three segments: Medical Device Manufacturing, Personal Care Services, and Medical Products and Technologies. The Medical Device Manufacturing segment designs, manufactures, and distributes the Toxygen hardware system with disposables speculums and tubing. Its products are primarily used for bowel preparation prior to medical procedures, such as a colonoscopy and OB/GYN medical procedures; and for individuals seeking health and wellness prevention for good colon health. This segment serves health and wellness spas; endoscopy out-patient clinics; osteopathic physicians; hospital systems- veteran hospitals; skilled nursing homes; assisted living facilities; and individuals with disabilities, such as paraplegic, quadriplegic, and obesity through independent distributors or product re-sellers. The Personal Care Services segment provides non-medical, personal care attendant services, supervised independent living, long-term senior care, and other approved programs. The Medical Products and Technologies segment distributes durable and home medical equipment for respiratory therapy to patients with sleep obstructive disorders or related chronic illnesses. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.

191 Employees
Last Reported Date: 12/15/14
Founded in 1995

oncologix tech inc (OCLG) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $120.0K
Chief Financial Officer and Secretary
Total Annual Compensation: $80.2K
Compensation as of Fiscal Year 2014.

oncologix tech inc (OCLG) Key Developments

Oncologix Tech, Inc. Appoints Nikole Jessie as Director of Marketing and Public Relations

Oncologix Tech, Inc. announced the appointment of Nikole Jessie as the Director of Marketing and Public Relations. Ms. Jessie will be responsible for the development of marketing strategies for the OCLG subsidiaries products and services, manage public relations, investor relations activities, and will facilitate the branding of Oncologix Tech to its Company's shareholders, investors and customers. Ms. Jessie brings direct expertise in both private and public companies' delivery and execution of marketing programs. Prior to joining the Company, she was the Firm Administrator for Landmark Consulting, LLC.

Oncologix Tech Inc. Reports Revenue Results Third Quarter and Nine Months Ending May 31, 2015

Oncologix Tech Inc. reported revenue results third quarter and nine months ending May 31, 2015. For the quarter, the company’s revenues for were $1,235,656, up from $988,385, an increase of 25%, from the comparable periods in 2014. For the nine months, the company’s revenues were $3,625,407, up from $2,696,776, an increase of 34% from the comparable periods in 2014.

Oncologix Tech Eyes Acquisitions

Oncologix Tech, Inc. (OTCPK:OCLG) is looking for acquisitions. Wayne Erwin, Chief Executive Officer of Oncologix said, "With the continued improvement in our revenues, operating margins, along with our acquisition and growth plans, we are confident that our stock values will rise from its current, low levels. The Enterprise Values of the Company remains evident."


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLG:US $0.00 USD 0.00

OCLG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OCLG.
View Industry Companies

Industry Analysis


Industry Average

Valuation OCLG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOLOGIX TECH INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at